Florida Senate Bill 69 (2001)

An act relating to pharmacy; requiring the removal of specified drugs from the negative formulary for generic and brand-name drugs established in s. 465.025(6), F.S.; providing that the act does not amend existing law relating to a physician's authority to prohibit generic drug substitution by writing "medically necessary" on the prescription; providing an effective date.

Section 1
The Board of Pharmacy and the Board of Medicine shall remove any generic named drug product from the formulary established by s. 465.025(6), Florida Statutes, if every commercially marketed equivalent of that drug product is "A" rated as therapeutically equivalent to a reference listed drug or is a reference listed drug as referred to in "Approved Drug Products with Therapeutic Equivalence Evaluations" (Orange Book) published by the United States Food and Drug Administration.

Section 2
Nothing in this act shall alter or amend s. 465.025, Florida Statutes, as to existing law providing for the authority of physicians to prohibit generic drug substitution by writing "medically necessary" on the prescription.

Section 3
This bill shall take effect upon becoming a law.